CCOI VIDEO SERIES
This collection brings together seven concise briefings and interviews that capture CCOI’s latest work across leadership, policy, and translational science. Each piece distills the practical mechanisms—collaboration frameworks, standardized endpoints, clinical-trial networks, and data interoperability—that move innovations from concept to clinic.
From a global “moonshot” for diabetic retinal disease to on-label pediatric IOLs and the rise of clinical-trial Centers of Excellence, these videos offer focused perspectives for clinicians, researchers, industry partners, and regulators who are accelerating patient-centered ophthalmic solutions.
Ahead of the September 8 meeting in Paris, the program co-chair of the event and current president of the American Academy of Ophthalmology discusses how the workshop aims to shape consensus on guidelines, research priorities, and emerging therapies in myopia control.
As myopia rates continue to climb globally—emerging as a major concern not only in Asia but increasingly in the West—the upcoming Collaborative Community on Ophthalmic Innovation (CCOI) Myopia Workshop in Paris, France, on September 8, 2025, will spotlight urgent questions in research, treatment, and public health.
Dr. S. Robert Levine introduces the DRD Cure Accelerator—a cross-sector "moonshot" to end vision loss from diabetic retinal disease by coordinating research, partnerships, and translational pathways.
Dr. Natalie Afshari explains how aligning clinical evidence, professional-society support, and regulatory engagement—plus real-world data and registries—can expand on-label pediatric IOL access.
Dr. Jeffrey Goldberg outlines how clinical-trial Centers of Excellence can standardize infrastructure and training, cut start-up times, and improve data quality across sites.
President Joel S. Schuman previews CCOI's growth to 17 working groups and 80+ stakeholders, framing a transparent, global ecosystem to elevate ophthalmic product development.
At Stanford, leaders aligned on AI, real-world evidence, and clinical-trial networks—turning cross-sector collaboration into faster, higher-impact eye-health solutions.
Dr. Malvina Eydelman shares how CCOI is modernizing innovation pathways and uniting global stakeholders to advance patient-centered ophthalmic solutions.
In one of her first interviews as CEO, Dr. Eydelman lays out priorities to unite stakeholders, streamline processes, and prioritize patient outcomes across the innovation pathway.